We are a genetic medicines company focused on developing transformative therapies for rare, monogenic CNS disorders with limited or no approved treatment options. Our vision is to become the premier genetic medicines company by developing and ultimately commercializing therapies that dramatically and positively transform the lives of patients suffering from these life-threatening disorders.

  We intend to focus our search for an initial business combination on companies within the mobile application (“app”) ecosystem or consumer internet companies with enterprise valuations in the range of $500 million to $1.5 billion, though our search may span many consumer software segments worldwide. We intend to specifically focus on companies that have created compelling mobile […]

  Our selection process will leverage our founder’s and our Strategic and Operating Partners’ network of industry, private equity sponsor, credit fund sponsor and lending community relationships as well as relationships with management teams of public and private companies, investment bankers, restructuring advisers, attorneys and accountants, which we believe should provide us with a number […]

  We are mainly engaged in the production and sale of the following two eco-friendly construction materials: autoclaved aerated concrete blocks, and ready-mixed mortar, made from mining waste (iron tailings and copper tailings, etc.) and fly-ash, in and around the city of Nanjing, Jiangsu Province, China. We are a holding company and our primary business […]

  Our efforts to identify a prospective target business will not be limited to a particular industry or geographic location but will initially focus in Asia and North America. However, we believe we are particularly well-positioned to capitalize on growing opportunities created by technology developments in serverless and decentralized computing and file storage, IOT data […]

  While we may pursue a business combination target in any business or industry, we intend to search globally for companies in the energy efficiency, clean technology and sustainability sectors, with a focus on companies that we believe can be positioned for success in China, as well as other markets in Asia and beyond.

  We operate in the Chinese urban-rural design and development market, and provide two main services, (i) urban-rural design services and (ii) comprehensive construction project management consulting services. Urban-rural design and development is the process of designing and shaping the physical features of cities, towns and villages and planning for the provision of municipal services […]

  Fathom Holdings Inc. was founded in 2010 as a cloud-based, technology-driven real estate brokerage company. Our low-overhead business model leverages our proprietary software platform for management of real estate brokerage back-office functions, without the cost of physical brick and mortar offices or of redundant personnel. As a result, we are able to offer our […]

  We are a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, high-value frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. We define frontier targets as proteins that play an important role in cancer and for which there is either: […]

  Although we are not limited to a particular industry or geographic region for purposes of consummating an initial business combination, we intend to focus on businesses primarily operating in the financial services industry or businesses providing technological services to the financial industry, commonly known as “fintech businesses” in North America and the Asia-Pacific.